PSMA-based alpha therapy in prostate cancer
Eur J Nucl Med Mol Imaging
.
2023 Oct;50(12):3506-3508.
doi: 10.1007/s00259-023-06384-0.
Epub 2023 Aug 10.
Authors
Mike Sathekge
1
,
Alfred Morgenstern
2
Affiliations
1
Nuclear Medicine Research Infrastructure (NuMeRI), University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa. mike.sathekge@up.ac.za.
2
Joint Research Centre, European Commission, Karlsruhe, Germany.
PMID:
37561143
DOI:
10.1007/s00259-023-06384-0
No abstract available
Publication types
Letter
MeSH terms
Humans
Male
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms, Castration-Resistant*
Substances
Prostate-Specific Antigen